Format

Send to

Choose Destination
J Turk Ger Gynecol Assoc. 2012 Dec 1;13(4):227-32. doi: 10.5152/jtgga.2012.35. eCollection 2012.

C-reactive protein and lipoprotein-a as markers of coronary heart disease in polycystic ovary syndrome.

Author information

1
Department of Obstetrics and Gynecology, İstanbul Bilim University Avrupa Florence Nightingale Hospital, İstanbul, Turkey.

Abstract

in English, Turkish

OBJECTIVE:

The aim of this study was to investigate the risk factors of coronary heart disease, CRP and Lipoprotein-a in polycystic ovary syndrome patients.

MATERIAL AND METHODS:

Prospectively collected data of polycystic ovary syndrome patients (n=62) and control group (n=40) were compared.

RESULTS:

PCOS patients had higher HOMA-IR, CRP, DHEAS, free testosterone, FAI, LH and prolactin levels when compared to the control group. Lipoprotein-a levels did not differ between the groups. The obese PCOS group had statistically significantly higher fasting blood glucose, total cholesterol, triglyceride, free testosterone, insulin, CRP and HOMA-IR and statistically significantly lower HDL and SHBG when compared to normal weight PCOS persons. Fasting blood glucose, total cholesterol, LDL, SHBG, CRP, Lipoprotein-a, FSH, LH, TSH, DHEAS and prolactin levels did not differ between the normal weight and obese control groups.

CONCLUSION:

CRP levels increase in polycystic ovary syndrome patients and can be used as a marker of coronary heart disease. Future studies can be directed at treatments to decrease CRP levels, including antiinflammatory treatments.

KEYWORDS:

CRP; Polycystic ovary syndrome; coronary heart disease; lipoprotein-a; obesity

Supplemental Content

Full text links

Icon for Galenos Yayinevi Icon for PubMed Central
Loading ...
Support Center